Retraction: Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J 2012;53:931-9

Yonsei Med J. 2013 Jan 1;54(1):269. doi: 10.3349/ymj.2013.54.1.269.

Minkyu Jung^{1

2}, Se Hyun Kim^{1

2}, Soojung Hong^{1

2}, Young Ae Kang³, Se Kyu Kim³, Joon Chang³, Sun Young Rha^{1

2}, Joo Hang Kim^{1

2}, Dae Joon Kim⁴, Byoung Chul Cho^{1

2}

¹ Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
² Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
³ Division of Pulmonology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
⁴ Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.

No abstract available

Publication types